Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

Semaglutide use in patients with Type 2 diabetes was associated with reduced postoperative complications after 90 days, according to a study in the March 2025 i ...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

One week prior to the first injection, researchers invited participants to drink their preferred alcohol beverages over a two-hour ... showed that after treatment, those in the semaglutide group ...

In the week ending Feb. 13, 30-year fixed-rate mortgages averaged 6.87%, Freddie Mac announced Thursday, the lowest in nearly two months ... sales will rise in 2025 after touching a 30-year ...

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

Like all reputable services, you must undergo lab tests before a healthcare professional ... such as type 2 diabetes. Wegovy contains semaglutide, which is also the main ingredient in Ozempic.